Literature DB >> 18542732

Testosterone deficiency syndrome and prostate cancer: illustrative annotations for a debate.

Alvaro Morales1, Angela Black.   

Abstract

Entities:  

Year:  2008        PMID： 18542732      PMCID： PMC2422889          DOI： 10.5489/cuaj.528

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  11 in total

1.  Persistent intraprostatic androgen concentrations after medical castration in healthy men.

Authors:  Stephanie T Page; Daniel W Lin; Elahe A Mostaghel; David L Hess; Lawrence D True; John K Amory; Peter S Nelson; Alvin M Matsumoto; William J Bremner
Journal:  J Clin Endocrinol Metab       Date:  2006-08-01       Impact factor: 5.958

2.  The use of hormonal therapy in "andropause": the pro side.

Authors:  Alvaro Morales
Journal:  Can Urol Assoc J       Date:  2008-02       Impact factor: 1.862

Review 3.  Testosterone and prostate cancer: an historical perspective on a modern myth.

Authors:  Abraham Morgentaler
Journal:  Eur Urol       Date:  2006-07-27       Impact factor: 20.096

4.  Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

Authors:  J E Morley; F E Kaiser; H M Perry; P Patrick; P M Morley; P M Stauber; B Vellas; R N Baumgartner; P J Garry
Journal:  Metabolism       Date:  1997-04       Impact factor: 8.694

5.  Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.

Authors:  Michael F Sarosdy
Journal:  Cancer       Date:  2007-02-01       Impact factor: 6.860

6.  Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.

Authors:  Leonard S Marks; Norman A Mazer; Elahe Mostaghel; David L Hess; Frederick J Dorey; Jonathan I Epstein; Robert W Veltri; Danil V Makarov; Alan W Partin; David G Bostwick; Maria Luz Macairan; Peter S Nelson
Journal:  JAMA       Date:  2006-11-15       Impact factor: 56.272

7.  Testosterone replacement therapy after primary treatment for prostate cancer.

Authors:  Piyush K Agarwal; Michael G Oefelein
Journal:  J Urol       Date:  2005-02       Impact factor: 7.450

Review 8.  Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men.

Authors:  Joel M Kaufman; R James Graydon
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

9.  Influence of radical prostatectomy on serum hormone levels.

Authors:  L R Miller; A W Partin; D W Chan; D J Bruzek; A S Dobs; J I Epstein; P C Walsh
Journal:  J Urol       Date:  1998-08       Impact factor: 7.450

10.  Testosterone and erectile function recovery after radiotherapy and long-term androgen deprivation with luteinizing hormone-releasing hormone agonists.

Authors:  Derek R Wilke; Chris Parker; Adam Andonowski; Debbie Tsuji; Charles Catton; Mary Gospodarowicz; Padraig Warde
Journal:  BJU Int       Date:  2006-03-17       Impact factor: 5.588
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.